Compare DSGR & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DSGR | INSP |
|---|---|---|
| Founded | 1952 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 1995 | 2018 |
| Metric | DSGR | INSP |
|---|---|---|
| Price | $27.48 | $42.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 16 |
| Target Price | $35.00 | ★ $94.00 |
| AVG Volume (30 Days) | 50.6K | ★ 959.8K |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 212.50 | 179.43 |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $1,980,023,000.00 | $82,050,000.00 |
| Revenue This Year | $5.35 | $8.02 |
| Revenue Next Year | $3.79 | $8.11 |
| P/E Ratio | $2,746.00 | ★ N/A |
| Revenue Growth | 9.75 | ★ 62.18 |
| 52 Week Low | $19.02 | $38.91 |
| 52 Week High | $33.80 | $147.03 |
| Indicator | DSGR | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 53.54 | 43.13 |
| Support Level | $26.88 | $39.61 |
| Resistance Level | $27.85 | $44.98 |
| Average True Range (ATR) | 0.56 | 2.07 |
| MACD | 0.01 | 0.46 |
| Stochastic Oscillator | 60.86 | 57.83 |
Distribution Solutions Group Inc is a specialty distribution company providing value-added distribution solutions to the maintenance, repair and operations (MRO), original equipment manufacturer (OEM) and industrial technology markets. The company operates through four reportable segments: Lawson, TestEquity, Gexpro Services and Canada Branch Division. Lawson distributes specialty products and services to the industrial, commercial, institutional and government MRO marketplace. TestEquity, which generates maximum revenue, distributes test and measurement equipment and solutions, industrial and electronic production supplies and vendor managed inventory programs. Gexpro Services is a supply chain solutions provider. The company generates majority of its revenue from United States.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.